Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2022
Jun. 30, 2021
Current assets:    
Cash $ 3,804,000 $ 4,713,000
Accounts receivable 9,508,000 6,097,000
Inventories, net 20,934,000 10,513,000
Other current assets 577,000 417,000
Total current assets 34,823,000 21,740,000
Right of use asset 2,711,000 3,035,000
Property, plant and equipment, net 1,588,000 1,356,000
Other assets 89,000 131,000
Total assets 39,211,000 26,262,000
Current liabilities:    
Accounts payable 13,361,000 7,175,000
Accrued expenses 2,142,000 2,583,000
Line of credit 3,500,000
Deferred revenue 313,000 24,000
Customer deposits 690,000 171,000
Office lease payable, current portion 486,000 435,000
Accrued interest 2,000 2,000
Total current liabilities 20,494,000 10,390,000
Office lease payable, less current portion 2,493,000 2,866,000
Total liabilities 22,987,000 13,256,000
Stockholders’ equity:    
Preferred stock, $0.001 par value; 500,000 shares authorized; none issued and outstanding
Common stock, $0.001 par value; 30,000,000 shares authorized; 15,992,080 and 13,652,164 shares issued and outstanding at March 31, 2022 and June 30, 2021, respectively 16,000 14,000
Additional paid-in capital 95,369,000 79,197,000
Accumulated deficit (79,161,000) (66,205,000)
Total stockholders’ equity 16,224,000 13,006,000
Total liabilities and stockholders’ equity $ 39,211,000 $ 26,262,000